BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25216246)

  • 1. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).
    Ghodsinejad Kalahroudi V; Kamalidehghan B; Arasteh Kani A; Aryani O; Tondar M; Ahmadipour F; Chung LY; Houshmand M
    PLoS One; 2014; 9(9):e106656. PubMed ID: 25216246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
    Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
    PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
    Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
    Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the
    Monfermé S; Lasseaux E; Duncombe-Poulet C; Hamel C; Defoort-Dhellemmes S; Drumare I; Zanlonghi X; Dollfus H; Perdomo Y; Bonneau D; Korobelnik JF; Plaisant C; Michaud V; Pennamen P; Rooryck-Thambo C; Morice-Picard F; Paya C; Arveiler B
    Br J Ophthalmol; 2019 Sep; 103(9):1239-1247. PubMed ID: 30472657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
    Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene.
    Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W
    Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.
    Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C
    Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
    Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
    Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
    Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
    BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase gene mutations in the Chinese Han population with OCA1.
    Liu N; Kong XD; Shi HR; Wu QH; Jiang M
    Genet Res (Camb); 2014 Nov; 96():e14. PubMed ID: 25577957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism.
    Shah SA; Din SU; Raheem N; Daud S; Mubeen J; Nadeem A; Tayyab M; Baloch DM; Babar ME; Ahmad J
    Clin Exp Dermatol; 2014 Jul; 39(5):646-8. PubMed ID: 24934919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
    Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene.
    Chaki M; Mukhopadhyay A; Chatterjee S; Das M; Samanta S; Ray K
    Mol Vis; 2005 Jul; 11():531-4. PubMed ID: 16056219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.
    Chaki M; Sengupta M; Mukhopadhyay A; Subba Rao I; Majumder PP; Das M; Samanta S; Ray K
    Ann Hum Genet; 2006 Sep; 70(Pt 5):623-30. PubMed ID: 16907708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
    Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
    Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of oculocutaneous albinism type 1 (OCA1) in Indian families: two novel frameshift mutations in the TYR Gene.
    Sundaresan P; Sil AK; Philp AR; Randolph MA; Natchiar G; Namperumalsamy P
    Mol Vis; 2004 Dec; 10():1005-10. PubMed ID: 15635296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
    Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
    Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.